Affiliation:
1. Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland
2. Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland
Abstract
Lactoferrin (LF) is a multifunctional iron-binding glycoprotein that exhibits a variety of properties, such as immunomodulatory, anti-inflammatory, antimicrobial, and anticancer, that can be used to treat numerous diseases. Lung diseases continue to be the leading cause of death and disability worldwide. Many of the therapies currently used to treat these diseases have limited efficacy or are associated with side effects. Therefore, there is a constant pursuit for new drugs and therapies, and LF is frequently considered a therapeutic agent and/or adjunct to drug-based therapies for the treatment of lung diseases. This article focuses on a review of the existing and most up-to-date literature on the contribution of the beneficial effects of LF on the treatment of lung diseases, including asthma, viral infections, cystic fibrosis, or lung cancer, among others. Although in vitro and in vivo studies indicate significant potency of LF in the treatment of the listed diseases, only in the case of respiratory tract infections do human studies seem to confirm them by demonstrating the effectiveness of LF in reducing episodes of illness and shortening the recovery period. For lung cancer, COVID-19 and sepsis, the reports are conflicting, and for other diseases, there is a paucity of human studies conclusively confirming the beneficial effects of LF.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference211 articles.
1. Forum of International Respiratory Societies (2021). The Global Impact of Respiratory Disease, European Respiratory Society. [3rd ed.]. Available online: Firsnet.Org/Images/Publications/FIRS_Master_09202021.Pdf.
2. Prevalence and Attributable Health Burden of Chronic Respiratory Diseases, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017;Soriano;Lancet Respir. Med.,2020
3. Global Impact of Respiratory Disease;Levine;Chest,2022
4. The Clear and Persistent Impact of Air Pollution on Chronic Respiratory Diseases: A Call for Interventions;Forastiere;Eur. Respir. J.,2021
5. Kaczyńska, K., Zając, D., Wojciechowski, P., and Jampolska, M. (2021). Regulatory Peptides in Asthma. Int. J. Mol. Sci., 22.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献